









PharmacovigilancePharmacovigilance is the "science and activities relating to the detection, assessment, understanding and prevention of adverse effects or any other medicine-related problem".1
An adverse effect or adverse drug reaction (ADR) is defined by the Medicines and Healthcare products Regulatory Agency (MHRA) as "an unwanted or harmful reaction experienced following the administration of a drug or combination of drugs, and is suspected to be related to the drug. The reaction may be a known side effect of the drug or it may be new and previously unrecognised".2
Global Regulatory Services can provide companies with a complete Pharmacovigilance Package which includes the following:
Please contact us with your specific regulatory compliance requirements.
1World Health Organisation (2004) WHO policy perspectives on medicines – pharmacovigilance: ensuring the safe use of medicines. Geneva: WHO.
2Source: Medicines and Healthcare products Regulatory Agency (MHRA)
|


Global House, Painters Lane, Sutton, Ely,
Cambridgeshire, CB6 2NS, UK
Telephone: +44(0)1353 774000
E-mail: enquiries@globalregulatoryservices.com
Cambridgeshire, CB6 2NS, UK
Telephone: +44(0)1353 774000
E-mail: enquiries@globalregulatoryservices.com

